Ibiayi Dagogo-Jack

11PUBLICATIONS
81CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical physicsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 06, 2026
Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung Cancer.

Takashi Sakai, Zofia Piotrowska, Charlotte I Wang

|Oct 19, 2025
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.

Melissa L Johnson, Egbert F Smit, Enriqueta Felip

|Mar 07, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Clinical Insights.

Hedy L Kindler, Ibiayi Dagogo-Jack, Marc de Perrot

|Jan 08, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline Update.

Hedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova

|Jul 30, 2024
Administrative Alignment for Integrated Diagnostics Leads to Shortened Time to Diagnose and Service Optimization.

Miriam A Bredella, Florian J Fintelmann, A John Iafrate

|Nov 22, 2023
Targeted Approaches to Treatment of Pleural Mesothelioma: A Review.

Ibiayi Dagogo-Jack

Pageof 2

Frequent Collaborators

3 joint publications

Rebecca S Heist

3 joint publications

Mari Mino-Kenudson

2 joint publications

Suresh S Ramalingam

2 joint publications

Melissa L Johnson